Core Insights - Cronos Group Inc. reported a 21% year-over-year increase in net revenue for Q2 2025, reaching $33.5 million, driven by strong sales in Israel and international markets [1][10] - The company maintains a robust balance sheet with $834 million in cash and cash equivalents, providing flexibility for future growth and expansion [1][3] - PEACE NATURALS remains the leading cannabis brand in Israel, achieving record revenue and sales volume due to high demand for medical cannabis [1][16] Financial Performance - Net revenue for Q2 2025 was $33.5 million, an increase of $5.7 million from Q2 2024, attributed to higher cannabis flower sales and the consolidation of Cronos GrowCo [10] - Gross profit for Q2 2025 was $14.5 million, up 130% from the previous year, reflecting improved sales prices and production efficiencies [10][6] - The net loss for Q2 2025 was $38.5 million, a significant increase from the previous year's loss, primarily due to foreign exchange losses [10][36] Market Position and Strategy - Cronos Group's international strategy has led to significant margin improvements, with strong performance in the Canadian market despite supply constraints [2][3] - The Spinach brand achieved a 4.7% market share in Canada, while Lord Jones and PEACE NATURALS continue to perform well in their respective segments [11][14][16] - The company is expanding its presence in international markets, launching PEACE NATURALS in Australia, Malta, and Switzerland [17] Operational Developments - The expansion of Cronos GrowCo is complete, with expected sales contributions beginning in Fall 2025, aimed at fueling growth in both domestic and international markets [18] - Cronos Group made a strategic investment of approximately $18.5 million in High Tide Inc., enhancing its competitive position in the Canadian cannabis retail market [21] Brand Performance - The Spinach brand's gummies maintained a 19.9% market share in the edibles category, showcasing strong consumer loyalty [12] - Lord Jones Chocolate Fusions™ captured a 10.2% market share, reinforcing its position as a leading brand in the chocolate cannabis edible segment [14] - PEACE NATURALS continues to thrive in Israel, supported by advanced cultivation techniques and a strong operational team [16]

The results of operations data contained in this presentation are based on our preliminary, unaudited results of operations for the quarter ended June 30, 2025. Such preliminary data should not be viewed as a comprehensive statement of our financial results for the quarter ended June 30, 2025 CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS August 5, 2025 Disclaimers 2Q25 Earnings Presentation The forward-looking statements contained in this presentation are based on our current expectations and belie ...

Financial Performance - Total revenue reached $319.9 million, a 14% increase, driven by growth in Pawn Service Charges (PSC), merchandise sales, and scrap revenue[23] - EBITDA increased by 42% to $45.2 million, with an EBITDA margin of 141%, up 280 bps[28] - Diluted EPS increased by 38% to $033[27] - Pawn Loans Outstanding (PLO) reached a record $2932 million, up 12%[29] Segment Performance - U S Pawn segment revenue increased by 11% to $2200 million, with earning assets up 21%[64, 66] - Latin America Pawn segment revenue increased by 21% to $999 million, with earning assets up 18%[87, 90] Store Growth and Acquisitions - The company acquired 40 stores in Mexico under the Monte Providencia and Tu Empeño Efectivo brands[20] - Ten de novo stores were opened in Latin America, including 6 in Mexico, 3 in Guatemala, and 1 in El Salvador[20] - Three stores were acquired in the U S, including one luxury store in Miami Beach[20] Balance Sheet and Capital Allocation - The company's cash balance was $4721 million[18] - Approximately $20 million of shares were repurchased in Q3, with an additional $10 million repurchased in July[20]

Financial Performance - H1 2025 net sales decreased by 2.4% at constant currencies, totaling €1,077 million, with a comparative decline of 6.4% [2][10] - Adjusted EBIT for H1 2025 was €147 million, resulting in an adjusted EBIT margin of 13.7%, down from 14.9% in H1 2024 [3][11] - H1 2025 adjusted EPS was €2.35, compared to €2.95 in H1 2024, with free cash flow generation of -€14 million, a decline from €37 million in H1 2024 [4][12] Segment Performance - Human Expression segment saw Q2 2025 net sales of €253 million, down 6.1% at constant currencies, with H1 2025 net sales at €406 million, down 7.8% [7][18] - Flame for Life segment reported Q2 2025 net sales of €183 million, down 0.9% at constant currencies, with H1 2025 net sales decreasing by 8.6% [23][24] - Blade Excellence segment achieved Q2 2025 net sales of €157 million, up 19.9% at constant currencies, with H1 2025 net sales increasing by 15.6% [28][29] Geographic Performance - In Q2 2025, net sales in Europe increased by 6.8% at constant currencies, while North America saw a decline of 2.7% [33] - Latin America experienced a significant drop in net sales, down 14.3% in Q2 2025, while Middle East and Africa reported a slight increase of 2.6% [33] - H1 2025 net sales in Asia and Oceania decreased by 11.7% [33] Cost and Margin Analysis - H1 2025 gross profit margin was 48.5%, down from 49.3% in H1 2024, primarily due to higher raw material and electricity costs [10] - The adjusted EBIT margin for the Human Expression segment decreased to 11.0% in H1 2025, driven by increased costs and unfavorable performance [20] - Flame for Life adjusted EBIT margin fell to 28.6% in H1 2025, compared to 31.5% in the previous year, due to net sales decline and higher costs [27] Cash Flow and Net Position - H1 2025 free cash flow was negative at -€14 million, a significant decline from €37 million in H1 2024, attributed to lower operating cash flow and negative working capital changes [15][41] - The net cash position at the end of June 2025 was €21 million, down from €262 million at the end of June 2024 [16][44] Outlook - The company confirmed its 2025 outlook, expecting net sales growth between 0% and 3% at constant currency, with an adjusted EBIT margin around 15.0% and free cash flow above €240 million [9][13]

Financial Performance - Revenue was $1.8 billion, flat compared to last year, or down 2% in constant dollars[15] - Net debt decreased by $1.4 billion, a 20% reduction compared to last year[16] - Excluding lease liabilities, net debt decreased by $1.4 billion, a 27% reduction compared to last year[16] - Adjusted operating loss significantly beat guidance[15] - Loss per share (EPS) was ($0.30), with an adjusted EPS of ($0.24)[15] Brand Performance - The North Face revenue increased by 6%, or 5% in constant dollars[25] - Vans revenue decreased by 14%, or 15% in constant dollars, impacted by channel rationalization actions[25] - Timberland revenue increased by 11%, or 9% in constant dollars[25] - Other Brands revenue increased by 4%, or 2% in constant dollars, with Altra growing over 20%[25, 41] Outlook - Q2'26 revenue is expected to decrease by 4% to 2% in constant dollars[18] - Q2'26 adjusted operating income is projected to be between $260 million and $290 million[18]

Financial Performance - Q3 FY25 - Revenue for Q3 FY25 was $67.1 million, within the guided range of $67 million to $71 million[9] - Adjusted EBITDA for Q3 FY25 was $7.3 million, beating the constant currency guidance by $0.3 million[9] - Q3 FY25 Adjusted EBITDA was $7.3 million, a decrease of 47.5% compared to $13.9 million in Q3 FY24[15, 27] - Q3 FY25 revenue was $67.1 million, a decrease of 8.5% compared to $73.4 million in Q3 FY24[15, 27] Financial Performance - YTD Q3 FY25 - Revenue for YTD Q3 FY25 was $195.8 million, a decrease of 3.6% compared to $203.1 million in YTD Q3 FY24[15, 27] - Adjusted EBITDA for YTD Q3 FY25 was $17.0 million, a decrease of 47.3% compared to $32.3 million in YTD Q3 FY24[15, 27] - YTD Q3 FY25 Free Cash Flows were $10.6 million, compared to $30.6 million in Q3 FY24 YTD[15] Guidance Update for FY25 - Updated revenue guidance for FY25 is $265 million to $275 million, a decrease of $10 million from the previous guidance[9] - EBITDA guidance for FY25 is $28 million to $33 million, a decrease of $2 million at the low end from the previous guidance[9] Enterprise Division - North America - Billed Deferred subscription Revenue Balance was $45.0 million, compared to $47.2 million in Q3 FY24[16] - Subscription Revenue was $20.9 million, compared to $22.0 million in Q3 FY24[16] - Revenue was $37.1 million, compared to $40.6 million in Q3 FY24[16] - Unbilled Deferred Revenue Balance was $56.4 million, compared to $64.4 million in Q3 FY24[16] - Subscription & Subscription Services Revenue was $33.7 million, compared to $35.9 million in Q3 FY24[16] Education Division - Invoiced Amounts were $15.0 million, compared to $19.0 million in Q3 FY24[23] - Subscription & Subscription Service Revenue was $17.8 million, compared to $18.2 million in Q3 FY24[23] - Revenue was $18.6 million, compared to $20.2 million in Q3 FY24[23] - Deferred Subscription Revenue Balance was $34.1 million, compared to $28.2 million in Q3 FY24[23] - Subscription revenue increased 13% and Deferred Revenue balance grew 21% in Q3[14]

Core Insights - Cronos Group Inc. reported a 28% year-over-year increase in net revenue for Q1 2025, reaching $32.3 million, with a 33% increase on a constant currency basis [1][11] - The company maintains a strong balance sheet with $838 million in total cash and cash equivalents and short-term investments [1] - PEACE NATURALS remains the leading cannabis brand in Israel, achieving record net revenue and market share [3][19] Financial Performance - Net revenue for Q1 2025 was $32,262 thousand, up from $25,288 thousand in Q1 2024, marking a $6,974 thousand increase [6][11] - Gross profit increased to $13,734 thousand in Q1 2025, a rise of $9,251 thousand from Q1 2024, resulting in a gross margin of 43% compared to 18% in the previous year [6][8] - Net income for Q1 2025 was $7,723 thousand, a significant improvement of $10,207 thousand from a loss of $2,484 thousand in Q1 2024 [8][11] Market Position and Brand Performance - The Spinach brand ranked as the second most popular brand in Canada with a 4.6% market share and third in the flower category with a 5.1% market share [13] - SOURZ by Spinach captured a 20% market share in the gummy category, making it the best-selling gummy brand in Canada [14] - Lord Jones Chocolate Fusions™ achieved a 9.6% market share, ranking as the third best-selling chocolate cannabis edible brand in Canada [16] Strategic Initiatives - Cronos GrowCo's expansion is on track for completion in Q2 2025, which is expected to significantly increase cultivation capacity and meet growing demand [2][22] - The company has authorized a share repurchase program of up to $50 million, expected to commence on May 14, 2025 [10] - New product launches in Q1 2025 include strain-specific cannabis oils under the PEACE NATURALS brand, aimed at enhancing product offerings in international markets [19][20] Regulatory Environment - An anti-dumping duty of up to 165% on Canadian medical cannabis imports into Israel was proposed but later vetoed, although the Ministry of Economy intends to pursue the duty process [23]